BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Javaheri B, Herbert E, Hopkinson M, Al-Jazzar A, Pitsillides AA. Sost Haploinsufficiency Provokes Peracute Lethal Cardiac Tamponade without Rescuing the Osteopenia in a Mouse Model of Excess Glucocorticoids. Am J Pathol 2019;189:753-61. [PMID: 30664862 DOI: 10.1016/j.ajpath.2018.12.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Galea GL, Delisser PJ, Meakin L, Price JS, Windahl SH. Bone gain following loading is site-specifically enhanced by prior and concurrent disuse in aged male mice. Bone 2020;133:115255. [PMID: 31991251 DOI: 10.1016/j.bone.2020.115255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Estell EG, Rosen CJ. Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis. Nat Rev Endocrinol 2021;17:31-46. [PMID: 33149262 DOI: 10.1038/s41574-020-00426-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 16.0] [Reference Citation Analysis]
3 Javaheri B, Pitsillides AA. Aging and Mechanoadaptive Responsiveness of Bone. Curr Osteoporos Rep 2019;17:560-9. [PMID: 31760583 DOI: 10.1007/s11914-019-00553-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
4 Fuggle NR, Cooper C, Harvey NC, Al-Daghri N, Brandi ML, Bruyere O, Cano A, Dennison EM, Diez-Perez A, Kaufman JM, Palacios S, Prieto-Alhambra D, Rozenberg S, Thomas T, Tremollieres F, Rizzoli R, Kanis JA, Reginster JY. Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs. Drugs 2020;80:1537-52. [PMID: 32725307 DOI: 10.1007/s40265-020-01364-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
5 He W, Li C, Chen Q, Xiang T, Wang P, Pang J. Serum sclerostin and adverse outcomes in elderly patients with stable coronary artery disease undergoing percutaneous coronary intervention. Aging Clin Exp Res 2020;32:2065-72. [DOI: 10.1007/s40520-019-01393-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Windahl SH, Delisser PJ, Galea GL. Mapping Regional Cortical Bone Responses to Local Changes in Loading and Systemic Stimuli. Methods Mol Biol 2021;2221:275-89. [PMID: 32979209 DOI: 10.1007/978-1-0716-0989-7_16] [Reference Citation Analysis]
7 Bovijn J, Krebs K, Chen CY, Boxall R, Censin JC, Ferreira T, Pulit SL, Glastonbury CA, Laber S, Millwood IY, Lin K, Li L, Chen Z, Milani L, Smith GD, Walters RG, Mägi R, Neale BM, Lindgren CM, Holmes MV. Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics. Sci Transl Med 2020;12:eaay6570. [PMID: 32581134 DOI: 10.1126/scitranslmed.aay6570] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 25.0] [Reference Citation Analysis]
8 Golledge J, Thanigaimani S. Role of Sclerostin in Cardiovascular Disease. Arterioscler Thromb Vasc Biol 2022;42:e187-202. [PMID: 35546488 DOI: 10.1161/ATVBAHA.122.317635] [Reference Citation Analysis]